chrisvoncsefalvay/vaers-outcomes huggingface dataset:
terrible sore throat; splitting headache; This spontaneous case was reported by a nurse and describes the occurrence of OROPHARYNGEAL PAIN (terrible sore throat) and HEADACHE (splitting headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 024M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 25-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (terrible sore throat) and HEADACHE (splitting headache). At the time of the report, OROPHARYNGEAL PAIN (terrible sore throat) and HEADACHE (splitting headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 024M20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.
After receiving first moderna covid dose, pt was sitting in our waiting area and fainted, falling over sideways and hitting his head on the floor.  Technician, Intern, and myself were checking on patient immediately after he fainted.  He very quickly "came to" and we then helped him up and into the IMZ room to sit.  A store manager was very close when it happened and let other management know of code white.  While monitoring patient, I called 911 to get paramedics to the scene.  I stayed on the phone with them while monitoring patient and asking questions.  Paramedics soon arrived and a store manager began filling out incident form.  The paramedics assessed patient and asked if he would like them to take him to the hospital.  Pt declined.  We gave patient cold cloth, water, and ice pack.  He had a small bump on the upper right hand side of his forehead.  He was feeling much better when he left, had someone to drive him.  I encouraged the pt to go to ER if any pain, vision changes, headaches, nausea/vomiting.
This spontaneous report as received from an other health professional refers to a patient of unknown age and gender, with no concurrent conditions and medical history reported. On 05-AUG-2017, the patient was vaccinated with improperly stored (18 hours in temperature -12 Celsius degrees) PROQUAD lot # M041083, therapy type RHA, expiration date 04-APR-2018 (route of administration was not reported), for prophylaxis. Other suspect therapy included sterile diluent lot # K019027, expiration date 07-AUG-2017 (dose, frequency and route of administration were not reported). No adverse effects were reported. This is one of four reports from the same reporter. Sender's Comments: US-009507513-1709USA000305: US-009507513-1709USA000307: US-009507513-1708USA002682.
Fast heart beat. Resting rate staying in low 100's, even when sleeping - my normal resting rate is in high 70's/low 80's
fairly intense ringing in ears the day of vaccination, Tinnitus, so far persisting into the following day maybe not quite as intense but still irritating.
c/o generalized weakness, fatigue 20 mins post inject 162/100, P92; assessed per MD @ 2 hrs post inject BP 154/100, P88; states feeling better, less weak; 3 1/2 hrs post inject states feeling better; pt declined BP;
Red raised papules started to left arm on 7/14/16 and progressively spread over entire body causing itching. Child visited primary care provider on 7/25/16 and was started on Prednisone and Zyrtec by mouth and triamcinolone 5% topically. Rash continued to spread after being on medications for 6 days. Another doctor visit on 8/1/16 and was continued on Prednisone, Zyrtec and started on zantac by mouth for 9 days. Triamcinolone topically continued. Child has followup with doctor 8/11/16.
Area of circular redness, induration 2cm x 1.5cm on (L) upper leg at site of injection, appeared one wk. after injection.
Flushing/sweating, racing heart, and warmth over entire body. Initial BP 158/89 (pulse 80), 99% O2 sat. Final BP 135/80 (pulse 76), O2 sat 100%.
Patient presented  with acute right inguinal pain that started on 8/4/21. This was initially associated with nausea/vomiting which has since resolved. Etiology of nausea/vomiting thought to be r/t cannabis hyperemesis syndrome. Treated and discharged at patients request. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
red rash that appeared. It looks like a birthmark. It is reddish; lot of pain on my arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (red rash that appeared. It looks like a birthmark. It is reddish) and PAIN IN EXTREMITY (lot of pain on my arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 084J21A, 037C21A, 018B21A and 030M20A) for COVID-19 vaccination.   Concurrent medical conditions included Hypertension and Hypercholesterolemia.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (red rash that appeared. It looks like a birthmark. It is reddish) and PAIN IN EXTREMITY (lot of pain on my arm). At the time of the report, RASH ERYTHEMATOUS (red rash that appeared. It looks like a birthmark. It is reddish) and PAIN IN EXTREMITY (lot of pain on my arm) outcome was unknown.            No known allergies were reported. Patient was never been diagnosed with COVID.  High cholesterol medication and high blood pressure medication as concomitant medication.  The patient never had this before. patient was sore for many days.  No treatment medication was reported.
It was itchy; A one pus filled pimple at the site of injection; A one pus filled pimple at the site of injection / It was red\Red around the injection site; Still tender at the site of injection; Feeling of passing out; Arm was sore; Had sweating; Joint ache; Nausea / sick to stomach / a rolling feeling inside her stomach; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 20th October 2020, the patient received the 1st dose of Shingrix. On 20th October 2020, less than a day after receiving Shingrix, the patient experienced pain in arm, sweating, joint pain and nausea. On 21st October 2020, the patient experienced feels awful. On 10th November 2020, the patient experienced injection site eruption and injection site erythema. On 14th November 2020, the patient experienced injection site itching. In November 2020, the patient experienced injection site tenderness. On an unknown date, the outcome of the pain in arm, sweating, joint pain, nausea and feels awful were recovered/resolved and the outcome of the injection site eruption, injection site erythema, injection site itching and injection site tenderness were unknown.   It was unknown if the reporter considered the pain in arm, sweating, joint pain, nausea, feels awful, injection site eruption, injection site erythema, injection site itching and injection site tenderness to be related to Shingrix.  Additional details were received as follows: The patient had first dose of the Shingrix vaccine in her left arm and that night her arm was sore, and had sweating, joint ache, and nausea and the next day, she had the feeling of passing out, she was sick to her stomach with a rolling feeling inside her stomach, which all resolved. Three weeks later she had a one pus filled pimple at the site of injection and it was red and 4 days later it was itchy, and red around the injection site. At the time of reporting, the injection site was tender. The reporter consented to follow up.
Information has been received from a registered nurse concerning a 57 year old female patient with bipolar disorder, hypothyroidism, penicillin allergy and prednisone allergy and a history of post mastectomy for breast cancer, who on 23-FEB-2009 was vaccinated subcutaneously in the deltoid region with a 0.65 mL dose of ZOSTAVAX (Merck) (Lot #663895/0135Y). On 26-FEB-2009, the patient developed an injection site reaction. The area was raised, red, hard and warm. It was about the "size of a half dollar". The patient also experienced stomach upset, loss of appetite, nausea and felt lightheaded. The patient called the office. At the time of reporting, the patient had not recovered. Additional information has been requested.
Fever or Chills  Cough  Fatigue  Muscle or body aches  Headache  Congestion or running nose  Diarrhea
Redness and swelling to inj site - ADVIL relieved discomfort- cold pack to site 3-4xa day for couple days- RTC if not resolved.
Information has been received from a healthcare worker referring to multiple unspecified patients of unknown age and gender. Information about patients' concomitant medications, concurrent conditions and medical history was not reported. On multiple unspecified dates the patients received doses of improperly stored GARDASIL (lot#/expiration date, dose and route were unspecified). The reporter stated that the thermometer temperatures were out of correct storage range (low of 30.2 F and high of 50 F) for an unknown time frame. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Nausea, extreme joint pain, resulting in ANCA Vasculitis diagnosis.  Kidney biopsy, high does steroids, chemotherapy medication.
headache joint pain blurred vision tiredness diarrhea swelling feet numbness shortness of breath
acid reflex; Gas; This is a spontaneous report from a contactable 74-year-old male consumer (patient) reported for himself that she received dose 1 of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration on 17Feb2021, 09:00AM, at single dose in left arm for covid-19 immunization. The patient's medical history included liver receipient. Concomitant medications included tacrolimus (PROGRAF), omeprazole, sodium citrate and latanoprost. On 17Feb2021 13:00, the patient experienced acid reflex and gas. It was unknown if the patient received treatment for the events. The outcome of the events was not recovered.  Information on the Batch/Lot number has been requested.
Redness, swelling on left thigh at DTaP injection site. Tx: cold compress, Tylenol prn Pain.
tinnitus evaluated by EENT (no treatment), brain fog (no treatment - blood tests normal), heart rate irregularity now being evaluated by heart rate monitor
pt recv vax 26OCT97 & about 3 or 4 days later left arm was numb from elbow down, for day or two;ring & little finger are still numb today;
Arthritis Flare up; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (Arthritis Flare up) and PAIN IN EXTREMITY (Sore Arm) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 006B21A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Mar-2021, the patient experienced ARTHRITIS (Arthritis Flare up) and PAIN IN EXTREMITY (Sore Arm). At the time of the report, ARTHRITIS (Arthritis Flare up) and PAIN IN EXTREMITY (Sore Arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient stated that the event arthritis flare up was not related to his vaccine but rather because he had not taken extra strength Tylenol in 2 days after vaccination.   No concomitant information was reported. Treatment information was not reported.   This case was linked to MOD-2021-054307 (Patient Link).
Information has been received from a physician concerning a 12 year old female who on 24-JUN-2009 was vaccinated intramuscularly with the 0.5 ml first dose of GARDASIL (lot no. not reported). There was no concomitant medication. The physician reported that on 24-JUN-2009 the patient was still on the examination table when she experienced syncope. The patient was laid down on the table and recovered in seconds. Additional information has been requested.
I had elevated heart rate of 125, High blood pressure, light headed, nausea. I went to ER, at the ER they gave me IV with anxiety meds and anti nausea medicine. It lasted about 3 hours.
PATIENT WAS WAS VERY DIZZY,  SWEATING, TROUBLE BREATHING. GAVE EPIPEN AND CALLED AMBULANCE
Information has been received from a female consumer, who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Merck) (Lot # not reported). The consumer stated that she noticed a small rash at the injection site of where she received the ZOSTAVAX (Merck). The consumer stated that the pharmacist thought she had had the band-aid too long and just told her to wait a few days to see what happened. At the time of the report, the patient's outcome was unknown. No further information is available.
Severe headache, unable to left head from from pillow or open eyes without increased pain; unable to left head from from pillow or open eyes without increased pain; This is a spontaneous report from a contactable consumer, the parent. A 21-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 09Apr2021 at 15:45 (at the age of 21-year-old) as a single dose for COVID-19 immunisation. Medical history included Tourette's syndrome, anxiety, depression and allergy. The patient received unknown medications within two weeks of vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 20Mar2021 at 13:00 as a single dose for COVID-19 immunisation. On 10Apr2021 at 00:00, the patient experienced severe headache and was unable to lift head from pillow or open eyes without increased pain. Therapeutic measures were taken as a result of severe headache and open eyes without increased pain and included treatment with Tylenol, rest and hydration. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Prior to the vaccination, the patient was not diagnosed with COVID-19. The clinical outcome of the events, severe headache and was unable to lift head from pillow or open eyes without increased pain was resolved in Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Got covid 11 days after 1st dose/symptoms of covid-19 such as no taste and smell; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Got covid 11 days after 1st dose/symptoms of covid-19 such as no taste and smell) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Got covid 11 days after 1st dose/symptoms of covid-19 such as no taste and smell). At the time of the report, COVID-19 (Got covid 11 days after 1st dose/symptoms of covid-19 such as no taste and smell) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported by reporter Treatment information was not provided   This case was linked to MOD-2021-311265 (Patient Link).
Large rash on arm spreading slightly onto back. Will be calling to see pediatrician tomorrow first thing if not showing improvement.
severe pain in the muscles right arm; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (severe pain in the muscles right arm) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 078J21A, 011M20A and 011A21A) for COVID-19 prophylaxis.     Patient does not had a history of Myocarditis and Pericarditis. Patient does not had a history of Covid-19 infection.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Jan-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYALGIA (severe pain in the muscles right arm). At the time of the report, MYALGIA (severe pain in the muscles right arm) outcome was unknown.            No concomitant medications were reported. The patient did not have a history of Myocarditis and Pericarditis. Patient did not have a history of Covid-19 infection Patient's Cardiac Symptoms started after his second Primary series and were ongoing. Patient received third dose as a booster dose. No treatment medications were reported.   This case was linked to MOD-2021-220435 (Patient Link).
Patient complained of a red, sore, and swollen arm for duration of 1 week.
Information has been received from a healthcare worker concerning an unspecified number of patients of unknown age and gender. No concurrent or historical conditions were reported. On unspecified dates, the patient was vaccinated with (Oka/Merck) VARIVAX (route, dose, Lot# and expiration date not reported), but the vaccines had been exposed to temperatures warmer than 5F, which was outside of the recommended range. No adverse effects have been observed or reported. This is one of several reports received from the same reporter. Additional information has been requested.
PATIENT REPORTED TIREDNESS, FELL ASLEEP/OR PASSED OUT AND HIT HEAD AND HOUR AFTER FLU SHOT. PATIENT WENT TO HOSPITAL. IT'S BEEN REPORTED THAT PATIENT MAY HAVE HAD COVID AT TIME OF VACCINE, BUT NO INFORMATION TO CONFIRM.
High pitched screaming x 2-4 hours refused to nurse x 16 hours fuzzy/difficulty with sleeping.
psychosis, blacked out for a 4 hour period 7pm-11pm, had conversations with people but has no memory. Saturday morning, lost all concept of reality. Diagnosed with acute psychosis. Acted very out of character.  Went to ER received medication returned to base-line. Sunday morning went into another psychotic episode.  Medications had little affect on client according to his perspective.. Kept overnight in hospital. Returned to base-line on monday. No current follow-up.
Report A0384624A describes the occurrence of mercury poisoning in a 16 month old male who received hep B vaccine recombinant (Engerix B). This report was received as a result of litigation proceedings and has not been confirmed by a physician or other healthcare professional. The subject "was born a perfectly normal, healthy boy whose Apgar scores at birth were well within the normal range. Developmentally, neurologically and socially, the subject achieved every developmental milestone anticipated of all  normally developing children until the age of 16 months. The subject received injections of Engerix B on 11/29/95 (1617A2) and 2/2/95 (1943A2). The subject also received Tetramune 11/29/95, 2/2/96. 4/22/96 and 5/5/99; Hib titer 5/5/97; hep B 1/7/99, and Pnu-Imune 23 10/20/97. The attorney alleged that "At approximately 16 months of age, the subject was neurologically devastated by the accumulation of mercury in his body, having been exposed via intramuscular vaccinations, and suddenly regressed developmentally, losing milestones of neurological development previously achieved, specifically including but not limited to becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior and the loss of language skills, motor skills and affect." Information received on 10/22/02 did not specify the outcomes of these events. The events mercury poisoning and developmental regression in this report are considered medically serious (OMIC).
Itchiness, redness, and rash within 3 hours post vaccination. Began in armpits, then spread to bilateral flank area. Symptoms reduced after 12 hours after treating with BENADRYL PO, then reappeared approximately 24 hours after vaccination, treated with BENADRYL again, then symptoms completed cleared by 48 hours.
Chronic urticaria started 8-10 days after the booster shot (3rd dose of Moderna). I started getting red splotches and itching over my whole body. I also had spontaneous face swelling and a fat lip while just sitting at my desk working. Hives and itching persisted for 3-5 days until I saw a doctor.  He said they were hive-like symptoms and maybe dermatographia. I started taking cetirizine 10mg daily and the itching went away. However the random red splotches (hives) still show up randomly even a month later. Face still feels funny at least once a day as well. I tried stop taking cetirizine for a day and the itching comes back. After doing some research online I found some medical journal entries that are almost identical to mine. It is 100% a result of the Moderna booster shot. Several other patients had the exact same symptoms from the COVID-19 vaccine. I have never had any of these symptoms in my life before this.  Even with the itching gone, I still have dermatographia and now the chronic urticaria.
ended up in a quarantine with a dozen people sick; Initial information regarding an unsolicited valid non-serious social media case received from a non-healthcare professional (patient) on 05-Nov-2020.  This case involved a patient with unknown age and gender who ended up in a quarantine with a dozen people sick (illness), after receiving INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  On an unknown date in 1972, the patient received a dose of suspect INFLUENZA VACCINE produced by an unknown manufacturer (lot number and expiry date were not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date in 1972 (unknown latency), but in the same year of vaccine administration, it was reported that the patient got a flu shot in a school and the patient ended up in a quarantine with a dozen people sick (illness).  No relevant laboratory details were provided.  It was not reported if the patient received a corrective treatment.  Outcome of the event was unknown.  There will be no information available on the batch number for this case.